13F filer · CIK 923093 ↗

Tudor Investment

You are looking at Q1 2019. See the latest, Q2 2026 →

Reported value

$2.42B

−52% on the quarter before

Positions

1,074

402 new · 310 sold out

Top 10

24.3%

of the value

Est. gain

+$89.8M

on stocks held all quarter

Est. return

+13.1%

on those stocks since Q4 2018

Filed

May 15, 2019

On SEC EDGAR ↗

Positions as of Mar 31, 2019, from Tudor Investment's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.

Portfolio at a glance

  • New
  • Added
  • Cut
  • Same
  • Options

The 24 largest positions, 34% of the reported value, each sized by its share, colored by what the fund did with it since Q4 2018. Striped tiles are options.

Celgene Corporation4.7%
SPDR S&P 500 ETF Trust4.5%
Celgene CorporationPUT4.5%
SPDR S&P 500 ETF TrustPUT2.8%
Ishares Msci Emerging Markets - ETF1.7%
Twenty-First Century Fox Inc - Cl APUT1.5%
Ishares Jp Morgan Usd Emerging Markets Bond ETF1.3%
Walt Disney Company (The)1.2%Microsoft1.1%
Takeda Pharmaceutic-Sp ADR1.1%
Twenty-First Century Fox Inc - Cl ACALL1.1%
Bristol Myers Squibb CompanyCALL0.8%
Intel0.8%
SPDR S&P 500 ETF TrustCALL0.7%
Hanger Inc0.7%
Worldpay Inc - Cl A0.7%
Ishares Tips Bond ETF0.6%
Conocophillips0.6%
Medequities Realty Trust Inc0.6%
Simon Property Group Incorporated0.6%
Suntrust Banks Inc0.5%
Bristol Myers Squibb Company0.5%
Csx Corporation0.5%
Cme Group Inc0.5%

Largest buys

Since Q4 2018, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.

  1. Celgene Corporation~$112.2MAdded · 0.0% → 4.7%+1,189,780 shares
  2. SPDR S&P 500 ETF Trust~$109.1MNew · 0.0% → 4.5%+386,201 shares
  3. Celgene CorporationPUT~$108.7MNew · 0.0% → 4.5%+1,152,100 underlying
  4. Ishares Msci Emerging Markets - ETF~$41.7MNew · 0.0% → 1.7%+971,259 shares
  5. Twenty-First Century Fox Inc - Cl APUT~$36.3MNew · 0.0% → 1.5%+730,000 underlying
  6. Ishares Jp Morgan Usd Emerging Markets Bond ETF~$31.3MNew · 0.0% → 1.3%+284,000 shares
  7. Walt Disney Company (The)~$28.8MNew · 0.0% → 1.2%+259,596 shares
  8. Takeda Pharmaceutic-Sp ADR~$26.1MNew · 0.0% → 1.1%+1,279,098 shares
  9. Twenty-First Century Fox Inc - Cl ACALL~$25.6MNew · 0.0% → 1.1%+515,000 underlying
  10. Microsoft~$22.9MAdded · 0.1% → 1.1%+194,166 shares

Largest sells

Since Q4 2018, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.

  1. SPDR S&P 500 ETF TrustPUT~$2.42BCut · 43.5% → 2.8%−8,568,000 underlying
  2. SPDR S&P 500 ETF TrustCALL~$1.34BCut · 23.8% → 0.7%−4,754,400 underlying
  3. Twenty-First Century Fox Inc - Cl A~$74.1MSold out · 1.5% → 0.0%−1,539,901 shares
  4. Nxp Semiconductors Nv~$63.1MCut · 1.0% → 0.0%−714,401 shares
  5. Nxp Semiconductors NvPUT~$53.5MSold out · 1.1% → 0.0%−730,000 underlying
  6. Twenty-First Century Fox Inc - Cl APUT~$44.8MSold out · 0.9% → 0.0%−930,000 underlying
  7. Shire Plc - ADR~$43.3MSold out · 0.9% → 0.0%−248,510 shares
  8. Twenty-First Century Fox Inc - Cl ACALL~$24.8MSold out · 0.5% → 0.0%−515,000 underlying
  9. Walt Disney Company (The)PUT~$21.9MSold out · 0.4% → 0.0%−200,000 underlying
  10. Vectren Corp.~$17.0MSold out · 0.3% → 0.0%−236,528 shares

Holdings

As of Mar 31, 2019. Changes are in shares against Dec 31, 2018, so a price move alone never reads as a buy or a sale.

Positions, sorted by share of the portfolio
HoldingValue
Celgene CorporationCOMMON STOCK · shares +8,466% · price +47.2%4.7%$113.6M+$424,858
SPDR S&P 500 ETF TrustCOMMON STOCK · shares New4.5%$109.1M—
Celgene CorporationPUTCOMMON STOCK · shares New4.5%$108.7M—
SPDR S&P 500 ETF TrustPUTCOMMON STOCK · shares −97%2.8%$67.1M—
Ishares Msci Emerging Markets - ETFCOMMON STOCK · shares New1.7%$41.7M—
Twenty-First Century Fox Inc - Cl APUTCOMMON STOCK · shares New1.5%$36.3M—
Ishares Jp Morgan Usd Emerging Markets Bond ETFCOMMON STOCK · shares New1.3%$31.3M—
Walt Disney Company (The)COMMON STOCK · shares New1.2%$28.8M—
MicrosoftCOMMON STOCK · shares +703% · price +16.1%1.1%$26.2M+$452,833
Takeda Pharmaceutic-Sp ADRCOMMON STOCK · shares New1.1%$26.1M—
Twenty-First Century Fox Inc - Cl ACALLCOMMON STOCK · shares New1.1%$25.6M—
Bristol Myers Squibb CompanyCALLCOMMON STOCK · shares New0.81%$19.6M—
IntelCOMMON STOCK · shares +122% · price +14.4%0.79%$19.1M+$1.1M
SPDR S&P 500 ETF TrustCALLCOMMON STOCK · shares −99%0.73%$17.6M—
Hanger IncCOMMON STOCK · shares −2.6% · price +0.5%0.72%$17.3M+$91,668
Worldpay Inc - Cl ACOMMON STOCK · shares New0.66%$16.0M—
Ishares Tips Bond ETFCOMMON STOCK · shares −1.3% · price +3.3%0.64%$15.5M+$488,225
ConocophillipsCOMMON STOCK · shares New0.60%$14.6M—
Medequities Realty Trust IncCOMMON STOCK · shares New0.60%$14.5M—
Simon Property Group IncorporatedCOMMON STOCK · shares +158% · price +8.5%0.55%$13.3M+$403,980
Suntrust Banks IncCOMMON STOCK · shares +450% · price +17.5%0.54%$13.1M+$353,426
Bristol Myers Squibb CompanyCOMMON STOCK · shares +336% · price −8.2%0.51%$12.4M−$255,896
Csx CorporationCOMMON STOCK · shares +198% · price +20.4%0.50%$12.1M+$687,332
Cme Group IncCOMMON STOCK · shares +19% · price −12.5%0.48%$11.7M−$1.4M
Kar Auction Services IncCOMMON STOCK · shares New0.46%$11.2M—
Total · 1,074 positions100%$2.42B+$89.8M
The filing on SEC EDGAR ↗

Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.

What made money

From Q4 2018 to Q1 2019: 668 stocks held throughout, up $89.8M (+13.1%).

  1. Stamps.Com Inc34:1 split+$3.4M+1,679%
  2. Equinix+$1.8M+29%
  3. Evoqua Water Technologies Co+$1.6M+31%
  4. Yum China Holdings Inc+$1.4M+34%
  5. Snap+$1.3M+100%
  6. Hj Heinz Holding Corp−$480,629−24%
  7. Innoviva Inc−$550,763−20%
  8. New Oriental Education & Technology - Sp ADR1:9 split−$894,271−82%
  9. Cme Group Inc−$1.4M−13%
  10. Biogen Inc−$1.6M−21%

Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 4 splits read into the share counts.

Reported value by quarter

The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.

$80.00B$40.00B$0
Q1 2016Q2 2026
Every quarter's filing
Each quarter's 13F filing, newest first
QuarterReported valueFiling
Q2 2026$71.91B+33%SEC ↗
Q1 2026$53.87B−0%SEC ↗
Q4 2025$54.03B−7%SEC ↗
Q3 2025$57.98B+26%SEC ↗
Q2 2025$45.92B+53%SEC ↗
Q1 2025$30.10B+15%SEC ↗
Q4 2024$26.28B−4%SEC ↗
Q3 2024$27.48B+41%SEC ↗
Q2 2024$19.52B+24%SEC ↗
Q1 2024$15.72B+27%SEC ↗
Q4 2023$12.42B+25%SEC ↗
Q3 2023$9.97B+19%SEC ↗
Q2 2023$8.38B+30%SEC ↗
Q1 2023$6.46B+28%SEC ↗
Q4 2022$5.06B+9%SEC ↗
Q3 2022$4.63B+22%SEC ↗
Q2 2022$3.81B−11%SEC ↗
Q1 2022$4.27B−29%SEC ↗
Q4 2021$5.98B−3%SEC ↗
Q3 2021$6.16B+16%SEC ↗
Q2 2021$5.29B+6%SEC ↗
Q1 2021$4.99B+41%SEC ↗
Q4 2020$3.54B+54%SEC ↗
Q3 2020$2.30B+14%SEC ↗
Q2 2020$2.02B+81%SEC ↗
Q1 2020$1.12B−50%SEC ↗
Q4 2019$2.23B−23%SEC ↗
Q3 2019$2.91B−17%SEC ↗
Q2 2019$3.51B+45%SEC ↗
Q1 2019$2.42B−52%SEC ↗
Q4 2018$5.06B+27%SEC ↗
Q3 2018$3.98B+38%SEC ↗
Q2 2018$2.87B−7%SEC ↗
Q1 2018$3.09B−22%SEC ↗
Q4 2017$3.94B+0%SEC ↗
Q3 2017$3.92B+19%SEC ↗
Q2 2017$3.28B+1%SEC ↗
Q1 2017$3.25B−16%SEC ↗
Q4 2016$3.88B−9%SEC ↗
Q3 2016$4.27B−10%SEC ↗
Q2 2016$4.72B+21%SEC ↗
Q1 2016$3.91BSEC ↗

Get the newsletter

The day's AI and market news, in your inbox every weekday.